Skip to main content

Table 2 Clinical characteristics of patients whose serum was tested for PCSK9 levels. The patients with HCC had significantly higher PCSK9 than healthy controls, as well as those with cirrhosis and chronic hepatitis

From: Decreased PCSK9 expression in human hepatocellular carcinoma

Clinical characteristics HCC (N = 40) Cirrhosis (N = 13) Chronic Hepatitis (N = 38) Healthy controls (N = 6)
Average PCSK9 (ng/mL) 91.6 78.3 69.2 92.1
Alphafetoprotein levels 30.1 N.A. N.A. N.A.
Average tumor diameter (SD) 5.64 (3.88) N.A. N.A. N.A.
  1. SD = standard deviation, N.A. = not applicable